v3.26.1
Statements of Changes In Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 1,782 $ 33,160,576 $ (25,722,783) $ 7,439,575
Balance (in Shares) at Dec. 31, 2024 1,782,486      
Equity-based compensation - options 1,008,034 1,008,034
Issuance of common stock for consulting services $ 35 133,340 133,375
Issuance of common stock for consulting services (in Shares) 35,000      
Proceeds from sale of common stock under the ATM, net of issuance costs $ 186 3,198,413 3,198,599
Proceeds from sale of common stock under the ATM, net of issuance costs (in Shares) 186,294      
Exercise of stock options $ 3 31,994 31,997
Exercise of stock options (in Shares) 3,333      
Net loss (7,512,667) (7,512,667)
Balance at Jun. 30, 2025 $ 2,006 37,532,357 (33,235,450) 4,298,913
Balance (in Shares) at Jun. 30, 2025 2,007,113      
Balance at Mar. 31, 2025 $ 1,909 35,679,350 (29,568,163) 6,113,096
Balance (in Shares) at Mar. 31, 2025 1,909,732      
Equity-based compensation - options 489,144 489,144
Issuance of common stock for consulting services $ 10 103,490 103,500
Issuance of common stock for consulting services (in Shares) 10,000      
Proceeds from sale of common stock under the ATM, net of issuance costs $ 84 1,228,379 1,228,463
Proceeds from sale of common stock under the ATM, net of issuance costs (in Shares) 84,048      
Exercise of stock options $ 3 31,994 31,997
Exercise of stock options (in Shares) 3,333      
Net loss (3,667,287) (3,667,287)
Balance at Jun. 30, 2025 $ 2,006 37,532,357 (33,235,450) 4,298,913
Balance (in Shares) at Jun. 30, 2025 2,007,113      
Balance at Dec. 31, 2025 $ 2,338 41,696,533 (38,960,145) 2,738,726
Balance (in Shares) at Dec. 31, 2025 2,338,127      
Equity-based compensation - options 924,466 924,466
Proceeds from sale of common stock under the ATM, net of issuance costs $ 189 1,382,480 1,382,669
Proceeds from sale of common stock under the ATM, net of issuance costs (in Shares) 189,035      
Proceeds from warrant inducements, net of issuance costs $ 571 2,231,036 2,231,607
Proceeds from warrant inducements, net of issuance costs (in Shares) 571,430      
Proceeds from warrant issuances, net of issuance costs 2,633,345 2,633,345
Net loss (5,819,105) (5,819,105)
Balance at Jun. 30, 2026 $ 3,098 48,867,860 (44,779,250) 4,091,708
Balance (in Shares) at Jun. 30, 2026 3,098,592      
Balance at Mar. 31, 2026 $ 2,507 43,251,293 (41,456,685) 1,797,116
Balance (in Shares) at Mar. 31, 2026 2,506,817      
Equity-based compensation - options 672,102 672,102
Proceeds from sale of common stock under the ATM, net of issuance costs $ 20 80,084 80,104
Proceeds from sale of common stock under the ATM, net of issuance costs (in Shares) 20,345      
Proceeds from warrant inducements, net of issuance costs $ 571 2,231,036 2,231,607
Proceeds from warrant inducements, net of issuance costs (in Shares) 571,430      
Proceeds from warrant issuances, net of issuance costs 2,633,345 2,633,345
Net loss (3,322,565) (3,322,565)
Balance at Jun. 30, 2026 $ 3,098 $ 48,867,860 $ (44,779,250) $ 4,091,708
Balance (in Shares) at Jun. 30, 2026 3,098,592